2014-07-01 23:52:21 UTC

CGH Podcast July 2014: Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients

A “Perspectives in Clinical Gastroenterology and Hepatology” article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to first author Dr. Kathleen E. Corey of the Department of Medicine, Gastrointestinal Unit, Massachusetts General Hospital; Plus, summaries of top stories from this month's issue of GI and Hepatology News.

 

 

Corey KE, Chalasani N. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology & Hepatology 2014; July 12(7): 1077-1084
Abstract

 

 

Duration: 13.44m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

 

 

More on Non-Alcoholic Fatty Liver Disease (NAFLD)

Blog: Restricting Fructose to Reduce Fatty Liver Disease

Sept. 19, 2017

Researchers report that reducing dietary fructose decreases liver fat in children with obesity and metabolic syndrome. Read more in the AGA Journals blog.

Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis

Sept. 1, 2017

PDFF estimated by MRI scanners of different field strength and at different sites, accurately classifies grades and changes in hepatic steatosis when histologic analysis of biopsies is used as a reference.

What is the Best Management Strategy for Patients With NAFLD?

Aug. 8, 2017

It’s essential for physicians to consider patients with non-alcoholic fatty liver disease in a holistic manner. Read more in the AGA Journals blog.